400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / TGF-beta/Smad / PKC / Darovasertib
CAS No.: 1874276-76-2
Synonyms: LXS196;IDE196
LXS196 is a potent and orally active protein kinase C (PKC) inhibitor used for the treatment of uveal melanoma.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02601378 | Uveal Melanoma | Phase 1 | Recruiting | November 1, 2019 | United States, New York ... more >> Novartis Investigative Site Recruiting New York, New York, United States, 10032 Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 France Novartis Investigative Site Recruiting Paris, France, 75231 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Norway Novartis Investigative Site Recruiting Oslo, Norway, NO-0424 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28050 Collapse << |
实验方案
技术信息
CAS号 | 1874276-76-2 | 储存条件 |
|
|
分子式 | C22H23F3N8O | 运输 | 蓝冰 | |
分子量 | 472.47 | 别名 | LXS196;IDE196 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02601378 | Uveal Melanoma | Phase 1 | Recruiting | November 1, 2019 | United States, New York ... more >> Novartis Investigative Site Recruiting New York, New York, United States, 10032 Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 France Novartis Investigative Site Recruiting Paris, France, 75231 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Norway Novartis Investigative Site Recruiting Oslo, Norway, NO-0424 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28050 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网